Clinical characterization of colitis arising from anti-PD-1 based therapy

Clinical characterization of colitis arising from anti-PD-1 based therapy

Colitis is a frequent, clinically-significant immune-related adverse event caused by anti-programmed death-1 (PD-1). The clinical features, timing, and management of colitis with anti-PD-1-based regimens are not well-characterized. Patients with advanced melanoma that received either anti-PD-1 monot...

Full description

Bibliographic Details
Main Authors: Daniel Y Wang, Meghan J Mooradian, DaeWon Kim, Neil J Shah, Sarah E Fenton, Robert M Conry, Rutika Mehta, Ann W. Silk, Alice Zhou, Margaret L Compton, Rami N Al-Rohil, Sunyoung Lee, Amber L Voorhees, Lisa Ha, Svetlana McKee, Jacqueline T Norrell, Janice Mehnert, Igor Puzanov, Jeffrey A Sosman, Sunandana Chandra, Geoffrey T Gibney, Suthee Rapisuwon, Zeynep Eroglu, Ryan Sullivan, Douglas B Johnson
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:OncoImmunology
Subjects:
colitis
immune-related adverse events
anti-programmed-death-1
immunotherapy
melanoma
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1524695

Internet

http://dx.doi.org/10.1080/2162402X.2018.1524695

Similar Items